ArticleScientific reports2026
Synthesis and multipurpose assessment of Cu(II) and Pd(II) Schiff base complexes as catalysts and antimicrobial agents.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Schiff base derivatives of isatin were synthesized with tryptamine in excellent yields to explore their broad applications as ligand precursors. Further, the ligand was reacted with Cu(OAc)2.H2O and PdCl2(CH3CN)2 to form the corresponding complexes with a 1:2 metal-to-ligand stoichiometry. The ligand and its complexes were analyzed with various techniques, including UV, FTIR, ESI-MS spectroscopy, and some physicochemical methods. Thermal analysis displayed high stability, with the Cu(II) complex remaining stable upto 250 °C and the Pd(II) complex showed no major decomposition until 340 °C. The molecular composition was examined with the help of XRD and CHN techniques. The antimicrobial evaluations revealed that complexation significantly enhanced bioactivity compared to the free ligand. The complexes exhibited moderate to strong growth inhibition against bacterial (E. coli, P. syringae, S. aureus, and S. epidermidis) and fungal strains (A. flavus and C. albicans). Additionally, the synthesized complexes were utilized as catalysts in the Suzuki-Miyaura coupling reaction of bromobenzene and phenylboronic acid. Another catalytic proficiency in reductive degradation of common dyes, like methylene blue (MEB), Rhodamine-B (Rh-B), Congo red (CR), and methyl orange (MO), was investigated for copper and palladium complexes. Both metal complexes facilitated the reductive degradation of hazardous organic dyes, in aqueous media.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.